The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

HistoSonics today announced 12-month follow-up clinical data from its prospective HOPE4LIVER trials evaluating its ...

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver disease, according to findings in JAMA Internal Medicine.

Papillary renal cell carcinoma is a type of kidney cancer. The kidneys are two small organs that work to remove waste products from the blood. Papillary renal cell carcinoma (PRCC) forms in the cells ...

A groundbreaking new study suggests that a gut-dwelling bacteria may be behind the recent surge in early-onset colorectal cancer cases. The potential culprit? Colibactin, a toxin produced by ...

Following promising phase 1 data, TCMCB07 is being further evaluated in a phase 2 trial for the treatment of patients with stage IV colorectal cancer. The first patient with stage IV colorectal cancer ...

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Circulating cell-free DNA (cfDNA) methylation markers offer a promising approach for early cancer ...

This study aims to develop a safer and more effective CAR T cell therapy for hepatocellular carcinoma (HCC). While recent clinical trials have shown promise, IL15-GPC3-CAR T cells demonstrated a 33% ...